Cardiac arrest survivors treated with or without mild therapeutic hypothermia: performance status and quality of life assessment by unknown
Kowalik et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2014, 22:76
http://www.sjtrem.com/content/22/1/76ORIGINAL RESEARCH Open AccessCardiac arrest survivors treated with or without
mild therapeutic hypothermia: performance
status and quality of life assessment
Robert Kowalik1*, Ewa Szczerba1, Łukasz Kołtowski1, Marcin Grabowski1, Karolina Chojnacka2, Wojciech Golecki2,
Adam Hołubek2 and Grzegorz Opolski1Abstract
Background: Hypoxic-ischaemic encephalopathy is the main determinant of clinical outcome after cardiac arrest.
The study was designed to determine long-term neurological and psychological status in cardiac arrest survivors,
as well as to compare neuropsychological outcomes between patients treated with mild therapeutic hypothermia
(MTH) and patients who did not undergo hypothermia treatment.
Methods: The article describes a single-center, retrospective, observational study on 28 post-cardiac arrest adult
patients treated in the cardiac intensive care unit who qualified for MTH vs. 37 control group patients, hospitalized
at the same center following cardiac arrest in the preceding years and fulfilling criteria for induced hypothermia,
but who were not treated due to unavailability of the method at that time. Disability Rating Scale (DRS), Barthel Index
and RAND-36 were used to assess performance status and quality of life in both study groups after hospital discharge.
Results: There were no statistically significant differences in physical functioning found between groups either at the
end of hospital treatment or at long-term follow-up (DRS: p = 0.11; Barthel Index: p = 0.83). In long-term follow-up, MTH
patients showed higher vitality (p = 0.02) and reported fewer complaints on role limitations due to emotional problems
(p = 0.04) compared to the control group. No significant differences were shown between study groups in terms of
physical capacity and independent functioning.
Conclusion: To conclude, in long-term follow-up, MTH patients showed higher vitality and reported fewer complaints
on role limitations due to emotional problems compared to the control group. This suggest that MTH helps to preserve
global brain function in cardiac arrest survivors. However, the results can be biased by a small sample size and variable
observation periods.
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Nearly 275,000 out-of-hospital cardiac arrests (OHCA)
occur in Europe each year [1]. Sudden cardiac arrest
(SCA) is an abrupt loss of heart function leading to
cessation of normal circulation of the blood. The final
outcome is mostly determined by the onset of hypoxic-
ischaemic encephalopathy defined as irreversible, struc-
tural alterations in the central nervous system resulting
from transient global hypoperfusion of the brain tissue* Correspondence: rjkowalik@wp.pl
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unless otherwise stated.[2,3]. It accounts for over 60% of deaths in patients hos-
pitalized after OHCA and almost 25% of deaths in pa-
tients after in-hospital cardiac arrest following successful
cardiopulmonary resuscitation (CPR) [4,5]. Mild thera-
peutic hypothermia (MTH) is the only currently recom-
mended neuroprotective measure known to influence
outcomes in cardiac arrest survivors. The results of a
2012 Cochrane meta-analysis show that mild therapeutic
hypothermia is effective in improving neurological out-
comes at the end of hospital treatment (number needed
to treat [NNT] = 6) and increasing survival during hos-
pital stays (NNT = 7) in patients following OHCA [6].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Interpretation of scores in Glasgow Coma Scale
and Cerebral Performance Category Scale (neurological
status GCS ≥13 and CPC 1–2 was considered satisfactory)
GCS interpretation CPC interpretation
1. 13 points and above –
mild brain damage
1. A return to normal cerebral function
and normal living
2. 9–12 points – moderate
brain damage
2. Cerebral disability but sufficient function
for independent activities of daily living
3. 8 points and below –
severe brain damage
3. Cerebral disability, limited cognition,
inability to carry out independent existence
4. Coma
5. Brain death
CPC – Cerebral Performance Scale, GCS – Glasgow Coma Scale.
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on short-term outcomes. Cerebral Performance Category
Scale (CPC) is the most frequently used instrument for
the evaluation of neurological status in patients follow-
ing SCA. Few trials extended observation periods and
integrated psychological status assessment in the study
design. Quality of life and daily functioning of patients
after OHCA in MTH group and in controls were com-
pared by Bro-Jeppesen et al. using CPC, 36-item short
form health survey (SF-36) and Mini Mental State
Examination (MMSE) in 6 month follow-up. They de-
scribed better short-term outcomes measured by CPC
and no differences in long-term outcomes between the
groups when comparing results from SF-36 and MMSE
[7]. Wachelder et al. findings show that 74% of OHCA
survivors have a low participation level in society and
over 50% experience severe fatigue, 38% feelings of
anxiety and/or depression and 24% a decreased quality
of life [8]. Since data on the subject and the number of
publications is limited, the following study was designed
to determine the neurological and psychological status
in cardiac arrest survivors as well as to compare neuro-
psychological outcomes between patients treated with
MTH and patients who did not undergo MTH.
Methods
The article describes a single-center retrospective obser-
vational study. Twenty-eight adult patients treated in the
years 2011 to 2013 in the cardiac intensive care unit
(CICU) following OHCA who qualified for MTH were
enrolled in the study. The historical control group in-
cluded consecutive 37 adult OHCA patients hospitalized
at the same center between 2009 and 2011. Of note, the
hypothermia programme was initiated in 2011. Inclusion
in the study was not limited by an upper age limit, cardiac
rhythm at baseline, or time of return of spontaneous cir-
culation (ROSC). The type of cardiac arrhythmia leading
to SCA, time of CPR initiation and time of ROSC were re-
corded. Both groups received the same pharmacological
treatment according to post-resuscitation care guidelines.
Hypothermia protocol
The inclusion criteria were hospitalization due to SCA,
time between SCA and recruitment <4 h, age >18 years
old, systolic blood pressure >80 mmHg (with or without
inotropic agents), and a score in Glasgow Coma Scale
(GCS) ≤8 points at the time of recruitment. Exclusion
criteria included presence of diseases with short pre-
dicted life expectancy (including advanced heart failure),
initial body temperature <30°C, unconsciousness prior
to SCA, active bleeding, known congenital coagulation
disorders, hypoglycemia, other known cause of impaired
consciousness (drugs, head trauma, stroke), and preg-
nancy. MTH patients underwent cooling to a targettemperature of 33°C by use of a patient temperature
regulation system (Gaymar® Medi-therm III), adjusting
temperature by supplying temperature-controlled water
through a connector hose to a companion blanket. Core
body temperature was monitored with an esophageal
temperature probe. The temperature during the main
cooling phase (36 hours) was controlled and monitored
at given time intervals according to the local MTH
protocol. Despite the fact that most MTH protocols use
the 12–24 hour periods for main cooling phase, our
protocol has extended this phase based on local experi-
ence of cardiac intensive care physicians. During the
rewarming phase we aimed to achieve the temperature
change rate of 0.1°C per hour.
At the time of admission, the patient’s neurological
status was initially assessed using CPC and GCS.
Consecutive evaluation using both scales was performed
by a qualified neurologist immediately after completion of
the induced hypothermia procedure and discontinuation
of pharmacological sedation and analgesia. In the control
group, assessment was accomplished after cessation of
anaesthetic administration. Scores obtained at the end of
hospital treatment were used for calculations (see Table 1
for interpretation).Outcome assessment
Due to unavailability of instruments designed specifically
to assess performance status and quality of life in SCA
patients with hypoxic-ischaemic encephalopathy, we
have employed three generally accepted tool to assess
the overall health, functioning and quality of life, these
included: Disability Rating Scale (DRS) [9,10], Barthel
Index [11-13], and the RAND 36-Item Short Form
Health Survey[14-16] and a few additional items. This
assessment was preformed after hospital discharge. The
authors have fulfilled the formal requirements to use the
instruments, as well as obtained permission from the
local ethics committee of the Medical University of
Warsaw, Poland.
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arousal, awareness and responsivity, cognitive ability for
self-care activities, dependence on others, and psycho-
social adaptability. Each question has its own rating scale
and the score is inversely proportional to the level of func-
tioning in a given area. The total possible score ranges
from 0 (no disability) to 30 (death).
The Barthel Index measures patient performance in 10
activities of daily living (feeding, grooming, dressing,
bathing, toilet use, transfers from bed to chair and back,
mobility on level surfaces, climbing stairs, presence or
absence of urinary and faecal incontinence) and estab-
lishes the patient’s degree of independence. Scores are
obtained in 5-point increments using direct observation,
self-report, or responses from third parties. The total
possible score ranges from 0 to 100 points, with lower
scores indicating increased disability. For the purpose of
the study, it was established to describe the degree of
disability as mild (scores from 86 to 100 points), moder-
ately severe (21–85 points) or severe (0–20 points).
RAND-36 includes 11 questions comprising 36 state-
ments. The domains of role limitations due to emotional
problems, energy/fatigue, emotional wellbeing, social
functioning, and general health perceptions were ana-
lyzed. RAND −36 includes the same items as those in
the SF-36, but the recommended scoring algorithm is
somewhat different. Patients were asked to compare
pre-cardiac arrest state to their current medical status.
RAND allows the questionnaire to be adopted to differ-
ent circumstances upon the requirements of the study.
Data collection
Questionnaire answers were collected via telephone in-
terviews in May 2013. The authors of the study made an
attempt to contact all SCA survivors treated at the
Department of Cardiology after 2009 (22 control group
patients hospitalized in the years 2009–2010 and 17
MTH patients hospitalized between 2011 and AprilFigure 1 Methods of survey data collection.2013). In June 2013, questionnaires were sent to indi-
viduals unreachable via telephone. The patients were
asked to fill them out and send them back in the enve-
lope provided before the end of July 2013. Information
from 15 patients from the control group (68%) and 16
from the MTH group (94%) were received. Data con-
cerning deaths in long-term follow-up was obtained from
the national identification number database of the Polish
Ministry of Interior and Administration. Six individuals
were lost to follow-up (see Figure 1). The average time
interval between hospital discharge and follow-up data
collection was 290 (14–776) days in MTH patients and
1409 (1152–1592) days in the control group. In one case,
information regarding performance and functional status
was obtained from the family due to the patient’s absence.Statistics
Using the independent samples t-test, the MHT and
control groups were compared in terms of age, duration
of hospital stay (including number of days spent in the
cardiac intensive care unit), time interval between car-
diac arrest and the initiation of CPR, and time interval
between cardiac arrest and the return of spontaneous
circulation. The U Mann–Whitney test was used to
compare DRS, Barthel Index, GCS and CPC, and scores
for selected domains of the RAND-36 questionnaire.
Correlations between respective scores were calculated
using Spearman’s rank correlation coefficient. The chi-
squared test was applied to compare data regarding
clinical diagnosis and patient history. IBM SPSS Statis-
tics 21.0 was used for statistical calculations.Results
Total mortality (CPC 5) during hospitalization and 6-
month follow-up was 35.7% in the MTH and 45.9% in the
control group, respectively (p = 0.49).
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Patients representing both study groups were homoge-
neous in terms of demographic statistics, such as age,
sex distribution, cardiac arrhythmia leading to cardiac
arrest, presence of chronic conditions excluding heart
failure and arterial hypertension, which were more preva-
lent in the MTH group (Table 2). No statistically signifi-
cant differences were noted in the analyzed final discharge
clinical diagnoses.
Core body temperature at baseline averaged 35.95 ±
0.2°C. After the initial cooling phase (at the beginning of
the proper cooling process), the temperature was 35 ±
0.3°C. Temperatures measured during the cooling phase
at time intervals specified in the study protocol showed no
statistically significant difference between individual pa-
tients and averaged 33.3 ± 0.1°C. The mean rewarmingTable 2 Summary of clinical characteristics of the MTH
and control group patients
MTH (n = 16) Control group
(n = 15)
p-value (p)
Age (years+/− SE) 55.56 ± 2.8 59.4 ± 2.9 0.358
Sex 11 males 11 males 0.779
VF/VT 16/16 13/15 0.131
Asystole 0/16 1/15 0.294
Hypertension 13/16 7/15 0.044
Diabetes 4/16 3/15 0.739
Prior myocardial infarction 2/16 3/16 0.570
Peripheral atherosclerosis 2/16 0/16 0.157
Heart failure 7/16 1/16 0.018
Coronary heart disease 4/16 2/15 0.411
CABG 1/16 0/15 0.325
AF 3/16 1/16 0.316
Renal failure 2/16 1/16 0.583
Prior stroke 1/16 0/15 0.325
Hyperthyroidism 0/16 1/15 0.294
Hypothyroidism 0/16 1/16 0.294
Smoking 9/16 6/16 0.366
COPD/asthma 1/16 1/16 0.962
Dyslipideamia 9/16 6/15 0.366
Final diagnosis
STEMI 7/16 9/15 0.366
NSTEMI 2/16 3/15 0.570
Cardiac shock 2/16 4/16 0.318
Heart failure 2/16 3/16 0.570
Myocarditis 2/16 1/16 0.583
AF- atrial fibrillation, CABG – coronary artery by-pass grafting, COPD – chronic
obstructive pulmonary disease, MTH - mild therapeutic hypothermia, NSTEMI –
non-ST elevation myocardial infarction, STEMI – ST-elevation myocardial infarction
VF - ventricular fibrillation, VT - ventricular tachycardia. p<0,05 is considered
as significant.time was 871 ± 100.7 minutes until the target temperature
(36.6°C) was reached.
The mean time between SCA and the initiation of CPR
was 3.44 ± 2.8 minutes in the MTH group and 4.2 ± 0.6 mi-
nutes in the control group (p = 0.61). The average time
between SCA and ROSC was 15.1 ± 2.9 and 11.6 ± 2.92 mi-
nutes for the MTH and the control groups, respectively
(p = 0.32). The average duration of hospital stay in cardiac
arrest survivors was 22.3 ± 2.81 days, including 9.6 ±
1.0 days spent in the CICU in the MTH group and 22.6 ±
4.8 days, including 9.7 ± 1.8 days in the CICU in the
control group (p = 0.95 and p = 0.96, respectively).
Outcome assessment at hospital discharge
From the group of patients from whom long-term follow-
up was collected, 15 MTH patients scored ≥13 in GCS
and 1 individual fell into the moderate brain injury cat-
egory (GCS score 9–12) at the end of hospital treatment.
In the control group, 13 patients scored ≥13 points in
GCS and 2 individuals obtained between 9–12 points.
None of the patients scored 3–8 points at time of hospital
discharge. All study participants from whom long-term
follow-up was obtained scored 1–2 points on the CPC
scale at hospital discharge, independent of method of
treatment. The groups did not differ in scores in GCS and
CPC at baseline and at the end of hospital treatment.
Long-term outcome assessment – data on physical
functioning
The median scores for DRS and the Barthel Index in the
MTH group were 0 and 100 and in the control group, 1
and 100. There were no statistically significant differ-
ences found between groups in the long-term follow-up
assessed by those two scales (DRS: p = 0.11; Barthel
Index: p = 0.83). Eleven out of 16 patients (68.8%) scored
0 points in DRS (no disability) in MTH group, compared
to 4 out of 15 patients (26.7%) in the control group. In
10 out of 31 patients, employment prospect was impos-
sible to assess due to retirement or pension. In the
MHT group, 14 out of 16 patients (87.5%) scored over
85 points in the Barthel Index with 12 patients scoring
100 points; in the control group, 12 out of 15 patients
(80%) scored 100 points in the Barthel Index (see Tables 3
and 4).
Long-term outcome assessment – data on psychosocial
functioning and quality of life
In long-term follow-up, MTH patients showed higher
vitality (p = 0.02) and reported fewer complaints on role
limitations due to emotional problems (p = 0.04) com-
pared to the control group (Table 5). No differences
were noted in comparison in domains of emotional well-
being and social functioning. No statistically significant
differences were noted in self-assessed health change
Table 3 DRS results
DRS score Level of disability Control group (n) MTH (n)
0 None 5 11
1 Mild 3 1
2-3 Partial 4 2
4-6 Moderate 0 0
7-11 Moderately severe 3 1
12-16 Severe 0 1
17-21 Extremely severe 0 0
22-24 Vegetative state 0 0
25-29 Extreme vegetative state 0 0
DRS – Disability Rating Scale, MTH – mild therapeutic hypothermia, n-number
of patients.
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out of 16 MTH patients vs. 2 out of 15 patients from the
control group described their health status as consider-
ably or slightly better compared to pre-cardiac arrest
state. Eight out of 16 MTH patients vs. 5 out of 15 con-
trol group patients described their status as comparable,
and 4 out of 16 vs. 8 out of 15 patients described it as
slightly or considerably worse.
Patients from the control group more frequently re-
ported problems with everyday life functioning (6/15 pa-
tients vs. 3/14 patients, p = 0.04; two patients from the
MTH group did not answer this item). In the whole
study group, these problems included physical disability,
impaired memory, problems with emotion control and
logical reasoning, sexual dysfunction, low self-esteem,
and fear of another incident of arrhythmia or death. The
two groups did not vary in terms of post-cardiac arrest
rehabilitation services use, the number of rehospitaliza-
tions or use of nursing care. Only 9 patients, including 4
MTH (29%) and 5 control group (33%) individuals, used
rehabilitation services. Two patients representing both
study groups received nursing care. Seven out of 28 indi-
viduals (4 MTH and 3 control group patients) were
rehospitalized due to complications following cardiac
arrest.
A positive correlation was observed between DRS
score and vitality (r = 0.405; p = 0.04), as well as between
DRS score and social functioning (r = 0.391; p = 0.03).
Additionally, a trend was shown between general health
perceptions and DRS score (r = 0.351; p = 0.06). A negative
correlation was observed between Barthel Index scores
and the level of social functioning (r = −0.405; p = 0.02).
Discussion
The primary goal of the study was to obtain information
on the degree of independence in everyday life function-
ing of cardiac arrest survivors and their self-assessment
of health status before and after the incident. No signifi-
cant differences were shown between groups in terms ofphysical capacity and independent functioning as mea-
sured by DRS and Barthel Index. This appears to be as-
sociated with favorable neurological outcomes in both
study groups at the time of hospital discharge: all study
participants scored 1 or 2 points in the CPC scale, while
15/16 MTH patients and 13/15 control group patients
scored ≥13 points in GCS. Patients who died after hos-
pital discharge had a worse neurological status at the
end of hospital treatment. In terms of psychological
functioning, individuals undergoing MTH were found to
have higher levels of vitality and fewer limitations due to
emotional problems compared to the control group.
This may indicate that MTH after SCA helps to preserve
global brain function and results in fewer impairments
of functions which require global brain involvement.
These observations are consistent with the results ob-
tained by Elliott et al. [17], who analyzed data from 70
trials investigating quality of life after SCA in diverse
populations. These trials varied with regard to quality of
life assessment methods and follow-up periods that
ranged from 0 (evaluation at time of hospital discharge)
to 15 years. Forty-six trials have demonstrated good
quality of life in SCA survivors following hospital treat-
ment, whereas 7 proved it to be poor. In the remaining
17 studies, quality of life was described as neutral due to
social isolation, cognitive impairment, depression, or
anxiety. A secondary conclusion from this paper con-
cerned the variety of methods applied in the analyzed
studies that ranged from recognized assessment tools to
self-invented quality-of-life evaluation surveys, as well as
structured or unstructured patient or family interviews.
Adopted tools differed in terms of specificity, ranging
from general scales, such as CPC, to neurocognitive test
batteries designed to provide complex neuropsycho-
logical assessments [17]. As opposed to data cited above,
Reinhard et al. [18] demonstrated worse quality of life in
cardiac arrest survivors compared to the general popula-
tion as assessed by RAND-36. In long-term follow-up
(16–62 months after the incident), SCA survivors
showed significantly worse performance in terms of gen-
eral health perceptions, physical capacity, social func-
tioning, and role limitations due to emotional problems
compared to general population [18]. The studies de-
scribed above analyzed results of OHCA survivors
treated without MTH. The number of publications re-
garding therapeutic hypothermia treatment remains
even smaller. One of the studies by Storm et al. [19] fo-
cused on patients with ventricular fibrillation SCA and
assessed neurological outcome in the MTH vs. control
(normothermic) group. The results demonstrated that
patients undergoing MTH scored higher on the CPC
scale at time of hospital discharge compared to the con-
trol group. MTH patients showed better survival rates in
a 2-year follow-up compared to individuals treated with
Table 4 Barthel index results
Barthel index
score
Degree of impairment Control group (n) MTH (n)
86-100 Mild 12 14
21-85 Moderately severe 3 2
0-20 Severe 0 0
MTH – mild therapeutic hypothermia, n-number of patients.
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tion of therapeutic hypothermia were proven to be the
only factors influencing 2-year survival [19]. Bro-
Jeppesen et al. [7] analyzed quality of life and daily func-
tioning of patients after OHCA in MTH group and in
controls using CPC, SF-36 and Mini Mental State Exam-
ination (MMSE) in 6 month follow-up. In long-term
follow-up they did not observe differences between the
groups when comparing results in SF-36 and MMSE.
However in this study detailed dimensions of SF-36 were
not analyzed, and the authors observed a trend toward
lower scores in both sub-scores of SF-36 (role function-
ing and role emotion) in patients treated without MTH
which is similar to our results. In study by Bro-Jeppesen
et al. only patients with initial VF/VT rhythm were
interviewed in the long-term follow up [7].
In the presented study, positive assessment of health
status was associated with better physical capacity as
measured by DRS. Patients who scored higher on scales
measuring performance showed better social function-
ing. No statistically significant differences in general
health status were observed between groups when pa-
tients were comparing the follow-up period with prior
to the cardiac arrest status. However, as many as 25% of
the MTH patients described their health status as con-
siderably or slightly better compared to pre-cardiac ar-
rest state vs. 13% in the control group. Almost 50% of
patients from the MTH group vs. 33% of the control
group patients assessed their health as comparable,
whereas 25% vs. 53% described it as slightly or consider-
ably worse. These results are comparable with the onesTable 5 RAND-36 questionnaire results (the result
expressed as rank average is directly proportional to the
number of negative assessments of a given domain and
inversely proportional to the level of patient functioning
in the respective area)





Role limitations due to
emotional problems
18.83 12.17 0.037
Energy/fatigue 16.92 10.08 0.022
Emotional wellbeing 15.07 12.85 0.488
Social functioning 17.59 14.30 0.318
General health 17.71 12.47 0.102
MTH – mild therapeutic hypothermia, p<0,05 is considered as significant.reported by Wachelder et al. [8] who describe long-term
outcomes of OHCA survivors treated in years 2001–
2006. Quality of life assessed by SF-36 was decreased in
24% of patients in mean time follow-up of three years.
On contrary to our findings Wachelder et al. describe
more cognitive problems in patients treated with MTH.
In discussion however they underline that this may be to
selection bias which we avoided in our study by includ-
ing patients with similar GCS score upon admission [8].
Some of the reported complaints of patients after OHCA
can be suggestive of clinically overt depression or post-
traumatic stress disorder, both of which tend to occur
following cardiac arrest [20].
As was previously mentioned, due to the limited num-
ber of publications concerning the physical and psycho-
social status of cardiac arrest survivors, independent of
the method of treatment, it proves difficult to relate our
study results to existing literature. Adequate measure-
ment tools dedicated specifically to this group of pa-
tients are also lacking. The scope and degree of central
nervous system functional impairment resulting from
post-cardiac arrest encephalopathy is difficult to predict,
as it depends on a number of factors, including duration
of hypoperfusion and hypoxia, and individual capacity
for restoration of neuropsychological functions. Restric-
tion of blood flow appears to cause brain injury in a dif-
ferent mechanism of action than the absence of oxygen
supply. Ischeamia caused by brain hypoperfusion leads
to infarctions at the border zones between major cere-
bral arterial territories, whereas anoxia results in a more
diffuse neuronal injury, affecting various brain regions,
e.g. hippocampus or cerebral cortex. Anoxic injury can
further be aggravated by a developing brain oedema and
damage caused by the restoration of blood flow, which
can be prevented by the induction of an almost routinely
used mild therapeutic hypothermia [21,22].
ILCOR recommendations state that unconscious adult
patients with spontaneous circulation after OHCA
should be cooled to 32°C to 34°C for 12 to 24 hours
[23]. In our study the duration of MTH was 36 hours.
This longer time of cooling is recommended by Polish
Registry of Therapeutic Hipothermia Guidelines [24]. In
2010 a survey evaluating level of therapeutic hypothermia
implementation in intensive care units in Poland was
carried out. According to this registry up to 26% ICUs
continued therapeutic hypothermia for longer that 24 h in
patients after cardiac arrest [25]. In comparison in United
Kingdom 13% of ICUs maintained cooling phase for
>24 hours after cardiac arrest [26]. There are several data
that point to potentially beneficial impact of longer-lasting
MTH. In rats after induced cardiac arrest it has been
shown that therapeutic hypothermia lasting 48 h com-
pared to 24 h correlated with greater surviving neuron
count [27]. A small sample study suggests that MTH
Kowalik et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2014, 22:76 Page 7 of 8
http://www.sjtrem.com/content/22/1/76lasting 72 h after cardiac arrest possibly blunts the inflam-
matory response after rewarming and may lower second-
ary brain injury [28]. In infants with hypoxic-ischemic
encephalopathy, hypothermia of 33- 34°C lasting for 72 h
is considered safe, improves survival rate and neurodeve-
lopmental outcome [29]. In traumatic types of brain injury
following cerebral contusions and elevated intracranial
long-term hypothermia, up to 5 days significantly im-
proves outcomes in patients without causing signifi-
cant complications [30]. On the other hand Shinozaki
et al. [31] found out that the optimal duration of well-
controlled hypothermia (33°C ± 1°C) is over 18 hours
and independently correlates with favorable neurological
outcome at 6 month follow-up in patients after OHCA.
Key limitations concerning assessment of physical
functioning, performance, and quality of life in cardiac
arrest survivors in long-term follow-up in the presented
study include a small study population and variable ob-
servation periods. This trial should be regarded as pilot
study and large, randomized trials using relevant existing
instruments or evaluation tools developed specifically
for patients following cardiac arrest should be performed
to provide broader information. Our results might be
partly influenced by the fact that due to organizational
reasons only 9 out of 25 patients received a post-
hospital rehabilitation, a treatment that has been proved
to significantly improve long-term outcomes. Another
limitation of our trial is the fact that the collection of re-
sponses to the questionnaires has been performed even
as long as fours years after the index incidence. This
may be a confounding factor more pronounced for the
historical cohort that was hospitalized between 2009 and
2011. Presented results may be also altered by varied
time of follow-up period ranging from 14 to 776 days in
the MTH group. The questionnaires themselves have
also several limitations. In small population samples the
results of DRS, Barthel Index and RAND-36 can be diffi-
cult to interpret due to floor and ceiling effect. In our
group we observed that high percentage of patients
achieved 100 points in Barthel Index and 0 points in
DRS pointing to good functioning in the examined as-
pects of life. Those questionnaires do not allow to diag-
nose subtle deficits in physical, independent functioning.
Conclusion
In conclusion, as compared to historical cohort of patients
after OHCA, patients treated with MTH report higher vi-
tality and less emotional constrains. No significant differ-
ences were observed between study groups in terms of
physical capacity and independent functioning. A dedicated
health related quality of life tool is needed to precisely and
adequately assess patients treated with MTH. Further ran-
domized, controlled trials are needed to confirm the above
results in the era of dedicated cooling devices.Abbreviations
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